ÂÜÀòÂÒÂ×

Maximilian Häfner is a Senior Scientist in New Modalities Medicinal Chemistry within early CVRM at AstraZeneca, where they have worked since 2021. With approximately four years of experience in the pharmaceutical industry, they specialize in small molecules, peptides, and oligonucleotide conjugates. Maximilian holds a PhD in Synthetic Organic Chemistry from the University of Konstanz, where they conducted total synthesis of natural products and supervised undergraduate students. They are known for their strong collaboration skills in multicultural teams and their commitment to scientific knowledge sharing.